Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 41

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 41
---
AC Shareholder Redemption Right. “Redemption Reversals” means the irrevocable reversal by the SPAC Shareholders of their SPAC Shareholder Redemption Rights. viii “Registration Rights and Lock -UpAgreement” means that certain Registration Rights and Lock -UpAgreement to be entered into in connection with the Closing by and among the Company, Parent, SPAC, Sponsor, SPAC Shareholders, CIBIC, Bioceres S.A, Theo and Heritas Key Personnel substantially in the form attached to the Business Combination Agreement as Exhibit F. “Restructuring” means the restructuring and transactions set forth in Schedule 8.12 of the Business Combination Agreement providing for the (i) the contribution and cancellation of the Restructuring Indebtedness or (ii) the extension of the maturity of such loans. See “ Certain Relationships and Related Party Transactions.” “Restructuring Indebtedness” means any Indebtedness owed by the Company and Heritas Argentina to the Parent and its affiliates. “SEC” means the U.S. Securities and Exchange Commission. “Securities Act” means the Securities Act of 1933, as amended. “SPAC Class A Ordinary Shares” means class A ordinary shares, par value $0.0001 per share, of SPAC. “SPAC Class B Ordinary Shares” means class B ordinary shares, par value $0.0001 per share, of SPAC. “SPAC Disclosure Letter” means disclosure letter delivered by SPAC to the Company on the date of the Business Combination Agreement. “SPAC Fundamental Representations” means the representations and warranties made pursuant to Section 5.1 (SPAC Organization) (other than the second sentence of Section 5.1), Section 5.2 (Due Authorization), Section 5.4 (No Conflict), Section 5.8 (Governmental Authorities; Consents), Section 5.13 (Capitalization of SPAC) and Section 5.14 (Brokers’ Fees) of the Business Combination Agreement. “SPAC Material Adverse Effect” means any Event that (i) has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, assets and liabilities, results of operations or financial condition of SPAC, taken as a whole or (ii) does or would reasonably be expected to, individually or in the aggregate, prevent or materially delay or materially adversely affect the ability of SPAC to consummate the